The Pilot and Feasibility (P and F) Program, directed by Dr. Sally Radovick, of the Baltimore Diabetes Research and Training Center (DRTC) is seeking applications to support new initiatives in diabetes-related biomedical, epidemiological or behavioral research. The Baltimore DRTC is an NIH-funded joint-venture between the Johns Hopkins University and the University of Maryland. It is composed of Cores that are designed to support research in diabetes and related endocrine and metabolic diseases. The Baltimore DRTC is one of seven national centers.
Monetary awards funded by the P and F program provide limited support to the development of preliminary data sufficient for the funding of a research grant application, or to the testing of an innovative hypothesis which might have important implications or yield significant results for diabetes-related research.
Faculty members at the University of Maryland, Howard University or Johns Hopkins University who are (1) new investigators without current or past NIH support as principal investigators, OR (2) established grant supported investigators who have not previously worked in diabetes-related areas (3) OR established investigators in diabetes-related areas with a proposal for testing the feasibility of a new or innovative idea that is both diabetes-related and represents a clear and distinct departure from his/her ongoing research interests.
Applications for collaborative projects are strongly encouraged.
After receiving the submissions, the P and F Steering Committee will review the applications for compliance with administrative guidelines. The proposals will then be sent to two reviewers, generally from outside the institution, for peer review. We plan to award up to 3 applications this year depending on the number of fundable applications and the availability of funds.
- Pilot and Feasibility (P and F) Submission Form (available for download on this website)
- NIH PHS 398 Form Page 2: Summary, Relevance, Project/Performance Sites, Senior/Key Personnel, Other Significant Contributors, and Human Embryonic Stem Cells.
- NIH PHS 398 Form Page 4: Detailed Budget for Initial Budget Period (4/1/2012-3/31/2013) *
- NIH PHS 398 Form Page 5: Budget for Entire Proposed Project Period (Includes Budget Justification)*
- Biographical Sketch in NIH PHS 398 format.
- Research Plan on NIH PHS 398 Continuation Pages (see section PHS 398: Part I I-42 of PHS 398 Instructions for details; follow all instructions) Please limit your research plan to 3,000 words, not including references.
- A Brief Candidate Background Description, limited to 350 words, on NIH PHS 398 Continuation Page.
*The proposed budget for each award may be up to $50,000 year in direct costs (no indirect costs). One year of funding will be awarded. A second year of funding will be possible if productivity is demonstrated and if/when the DRTC is competitively renewed during the next cycle.
Pilot and Feasibility (P and F) Submission Form is attached.
All other forms are available athttp://grants.nih.gov/grants/funding/phs398/phs398.html.
Please submit your application via email by 5:00pm on Monday, February 04, 2013 as one PDF file to Syntyche Walker.
Awards will be presented during the 2013 Annual Diabetes Research Training Center Symposium.
First Joint DRC/NORC Symposium & Reception
Thursday, May 2, 2013, 2:00 - 6:30 pm
SMC Campus Center Elm Room A (Ballroom A), University of Maryland, Baltimore Campus.
The Keynote Address will be delivered byMitchell A. Lazar, MD, PhD, Sylvan H. Eisman Professor of Medicine and Chief, Endocrinology, Diabetes & Metabolism Division, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. The title of Dr. Lazar's presentation will be:
"Circadian and Epigenomic Regulation of Metabolism"
Click this link to RSVP: http://www.doodle.com/tsgghwdcdxgzvptx
The Johns Hopkins University School of Medicine
Department of Pediatrics
Divisions of Endocrinology and Metabolism
Role of Lipolysis in Intermittent-Hypoxia Induced Insulin Resistance
Jonathan Jun M.D., Johns Hopkins University
Identifying Signaling Pathways Involved in the Differentiation of Human Embryonic Stem Cells to Insulin Producing Cells
Michael Parsons, Ph.D., Johns Hopkins
mHealth Activity Behavior Intervention for Older Adults with Diabetes
Charlene Quinn, Ph.D., University of Maryland
The Role of Co‐Activator p300 in Regulating Hepatic Gluconeogenesis
Ling He, M.D., Ph.D., Johns Hopkins University
Estrogens Regulate Endocrine Influences of Adipose Tissue on Skeletal Muscle
Espen E. Spangenburg, Ph.D., University of Maryland
The Role of Adipocyte ACOT7 in Diabetic Dyslipidemia
Michael J. Wolfgang, Ph.D, Johns Hopkins University
The Origin, Metabolism, and Pathology of Ovarian Glucose
Charles Chaffin, Ph.D., University of Maryland
Hyperandrogenism and Polycystic Ovarian Syndrome in the Old Order Amish
Sara DiVall, M.D., Johns Hopkins University; Patrick McArdle, Ph.D., University of Maryland
Influences of Prenatal Nutrition, Genetics, Childhood Growth Trajectory, Sexual Maturation, and their Interactions on
Metabolic Outcomes during Puberty: A Twin Study
Youfa Wang, M.D., M.S., Ph.D., Johns Hopkins University
Formative Research for a Prepared Food Source Intervention to Reduce Diabetes Risk Among Urban African Americans
Joel Gittelsohn, Ph.D., Johns Hopkins University
Pilot Study on the Use of OmniPod Subcutaneous Insulin Delivery Pump in Hospitalized Patients
Kristi D. Silver, M.D., University of Maryland
Characterizing the Metabolic Function of a Novel Adipokine, CTRP12
Guang William Wong, Ph.D.
Examining the Relationship Between Stress, Dietary Lapse and Weight Regain Among Weight-Reduced Adults with Type 2 Diabetes
Lawrence J. Cheskin, M.D., Johns Hopkins University
Promoting Islet Transplants by Targeting Fas Ligand
Abdel Hamad, D.V.M., Ph.D., Johns Hopkins University
Post-Translational Regulation of Glucokinase by Glucagon-like Peptide 1 (GLP1)
Mark A. Rizzo, Ph.D., University of Maryland
Return to DRC home